✦ LIBER ✦

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

✍ Scribed by Paula M. Fracasso; John A. Blessing; Kelly L. Molpus; Lisa M. Adler; Joel I. Sorosky; Peter G. Rose

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II evaluation of flavopiridol as

✍ Edward C. Grendys Jr.; John A. Blessing; Robert Burger; James Hoffman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Activity of paclitaxel as second-line ch

✍ Sarah Lincoln M.D.; John A Blessing Ph.D.; Roger B Lee M.D.; Thomas F Rocereto M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Phase II study of fulvestrant in recurre

✍ Allan L. Covens; Virginia Filiaci; Deborah Gersell; Christopher V. Lutman; Alber 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Phase II trial of cisplatin as first-lin

✍ Jt Thigpen; JA Blessing; H Homesley; WT Creasman; G Sutton 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II trial of clsplatin as first-lin

✍ J.Tate Thigpen; John A. Blessing; Howard Homesley; William T. Creasman; Gregory 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Phase II trial of gemcitabine as second-

✍ Katherine Y Look; Alan Sandler; John A Blessing; Joseph A Lucci III; Peter G Ros 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB